Nov . 19, 2026 16:26 Back to list
Sexually transmitted infections (STIs) are caused by various pathogens, including bacteria, viruses, and other microorganisms. Different infections may produce similar symptoms, while some individuals may have no noticeable symptoms. This makes accurate laboratory testing particularly important for identifying infections and supporting appropriate clinical management.
Traditional diagnostic approaches may require separate testing procedures for different pathogens. With the development of molecular diagnostic technology, multiplex detection methods have created new possibilities for identifying multiple infectious targets through a more integrated testing approach.
The Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit (Liquid) is designed to support molecular pathogen detection using PCR-based technology. Its multi-target detection concept addresses the need for broader STI testing, while its liquid reagent format provides a convenient presentation for molecular diagnostic workflows.
As a young and dynamic manufacturer specializing in molecular POCT in vitro diagnostic reagents, Cowin Gene is committed to developing innovative testing products that help make healthcare management more efficient, accessible, and intelligent.

STI testing involves identifying different infectious agents that may affect the reproductive and urinary systems. Because different pathogens can cause overlapping clinical symptoms, identifying the specific infectious agent is essential for appropriate clinical evaluation.
The Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit is designed around a multi-target molecular detection approach, supporting the detection of 14 STI-related targets according to its validated product specifications.
Compared with testing each pathogen individually, multiplex molecular testing can offer several potential advantages.
Multiple Target Detection
A multi-target assay is designed to identify multiple pathogen targets within a coordinated testing workflow, helping laboratories address different STI testing requirements.
More Comprehensive Testing Information
Different STI pathogens may require different clinical management strategies. Molecular detection can provide specific pathogen-related information to support clinical assessment.
Efficient Laboratory Workflow
Integrating multiple targets into a validated testing system may reduce the need for separate testing procedures, depending on the assay design and laboratory workflow.
Target-Specific Molecular Identification
PCR-based methods use specific genetic targets to identify pathogens, supporting more precise molecular detection than symptom-based assessment alone.
The exact 14 targets, specimen types, and reporting format should be confirmed through the manufacturer's official product documentation.
Polymerase Chain Reaction (PCR) technology is widely used in molecular diagnostics because it can amplify specific DNA sequences, allowing targeted genetic material to be detected in clinical samples.
For STI testing, PCR-based methods offer several important technical characteristics.
PCR amplification allows specific genetic sequences to be multiplied during the testing process. This supports the detection of targeted pathogen nucleic acids, including those present at relatively low concentrations.
Actual analytical sensitivity depends on the assay design, sample quality, extraction procedure, and validated detection limits.
Different infectious agents have different genetic characteristics. Specific primers and, where applicable, probes can be designed to recognize targeted pathogen sequences.
This helps distinguish different infectious targets within the assay's validated detection range.
Multiplex PCR methods can detect multiple genetic targets in one testing system. This approach can help diagnostic laboratories manage a wider range of pathogen detection requirements through an integrated workflow.
PCR-based molecular testing generally involves defined stages, including sample preparation, reagent preparation, amplification, quality control, and result interpretation.
Standardized procedures help improve operational consistency and support quality management in clinical laboratories.
A major consideration when selecting a multi-pathogen detection kit is the number and type of targets covered by the assay.
The Cowingene 14 Kinds of STI Detection Kit is designed to address multiple STI-related detection requirements within one molecular diagnostic product.
Different STI pathogens belong to different biological categories. These may include bacterial and viral pathogens, as well as other infectious microorganisms, depending on the specific assay panel.
A broader detection panel may provide useful testing information for healthcare institutions that need to evaluate multiple potential infectious causes.
When assessing a 14-target STI detection solution, laboratories should pay attention to:
These factors help healthcare professionals and laboratory managers evaluate whether a multi-target molecular diagnostic product meets their testing requirements.
An effective molecular diagnostic solution should support a clear and standardized testing process. Although exact procedures vary between products, PCR-based STI detection generally involves several stages.
Step 1: Sample Collection
Clinical specimens should be collected according to the sample types and collection procedures validated for the assay. Appropriate specimen handling is important for maintaining sample quality.
Step 2: Nucleic Acid Extraction
Depending on the product design, nucleic acid extraction may be required to obtain the target genetic material from the clinical specimen.
Step 3: Liquid Reagent Preparation
The liquid reagents should be prepared and handled according to the manufacturer's instructions. Proper storage, reagent handling, and preparation procedures help maintain testing consistency.
Step 4: PCR Amplification and Detection
The prepared reaction is processed using a compatible PCR instrument. Specific genetic targets are amplified and detected according to the assay's validated methodology.
Step 5: Result Analysis
The testing system generates results that should be interpreted according to the manufacturer's instructions and applicable clinical guidelines.
A positive molecular result indicates the detection of a targeted pathogen-related nucleic acid sequence. Clinical diagnosis and treatment decisions should be made by qualified healthcare professionals.
Molecular STI detection products can support different healthcare and laboratory testing environments.
Hospitals require reliable laboratory testing solutions to support the identification of infectious diseases. Multi-target molecular assays can help laboratories manage different STI detection requirements.
Independent diagnostic laboratories may need flexible molecular testing products that support multiple pathogen targets and standardized testing workflows.
STI testing is an important part of reproductive and sexual health management. Molecular detection can provide useful information for healthcare professionals evaluating potential infections.
Appropriate molecular diagnostic methods can support infectious disease surveillance and testing programs when used within validated public health frameworks.
For medical distributors and diagnostic product suppliers, multi-target STI detection kits represent an additional product category within the molecular diagnostics market.
Testing availability, clinical indications, and regulatory authorization should always follow local requirements.
Developing reliable molecular diagnostic products requires professional technical expertise, continuous innovation, and a clear understanding of clinical testing needs.
Cowin Gene specializes in developing and manufacturing molecular POCT in vitro diagnostic reagents. The company focuses on combining molecular technology with practical product design to improve diagnostic accessibility.
Its core advantages include:
Rapid Detection Time
Cowin Gene's molecular POCT products focus on efficient detection workflows, helping healthcare professionals obtain diagnostic information in a timely manner.
Easy Operation Procedure
Convenient operation procedures are an important part of the company's product development philosophy. Standardized workflows can help improve testing convenience for clinical and laboratory personnel.
High-Sensitivity Detection Performance
The company emphasizes high-sensitivity molecular detection through PCR-based diagnostic technology, addressing the requirements of pathogen identification.
Professional Development Team
With a professional team and an innovative mindset, Cowin Gene continuously develops molecular diagnostic products for different pathogen detection applications.
Diversified Diagnostic Product Portfolio
Beyond STI detection products, Cowin Gene's core product line includes PCR-based POCT diagnostic kits for detecting viruses, bacteria, and fungi.
This diversified product portfolio reflects the company's commitment to supporting different molecular testing needs.
For diagnostic laboratories, healthcare institutions, and international distributors, selecting a suitable STI detection kit involves evaluating several technical and commercial considerations.
Validated Pathogen Coverage: Confirm the exact 14 detection targets and their corresponding genetic sequences.
Analytical Performance: Review sensitivity, specificity, limit of detection, and cross-reactivity information.
Sample Requirements: Check the supported specimen types and sample preparation procedures.
Instrument Compatibility: Confirm compatibility with the intended PCR platform and laboratory equipment.
Reagent Storage: Review storage temperature, shelf life, transportation requirements, and handling instructions for the liquid reagent format.
Quality and Regulatory Documentation: Evaluate applicable certifications, product registration, quality management documentation, and market-specific compliance requirements.
A comprehensive evaluation helps buyers identify products that match their laboratory workflow and market requirements.
It is a molecular diagnostic product designed to detect multiple sexually transmitted infection-related targets within one testing solution. The exact 14 targets depend on the manufacturer's validated assay panel.
The product belongs to Cowin Gene's PCR-based molecular diagnostic product range. PCR technology amplifies specific genetic sequences to support pathogen detection.
Multiplex detection can support the identification of multiple pathogen targets within an integrated testing workflow, potentially reducing the need for separate assays.
Q4: What is the liquid reagent format?
Liquid reagent format refers to reagents supplied in a liquid formulation. Storage, preparation, and handling requirements should follow the manufacturer's instructions.
Qualified hospitals, clinical laboratories, diagnostic institutions, and authorized healthcare facilities may use validated molecular STI detection products according to their intended use.
A positive molecular result provides evidence that a targeted genetic sequence has been detected. Clinical interpretation, additional evaluation, and treatment decisions should be determined by qualified healthcare professionals.
The Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit (Liquid) is designed to support multi-target pathogen identification through PCR-based molecular diagnostic technology. Its integrated detection approach and liquid reagent format address important considerations in modern laboratory testing.
With a professional development team, an innovation-driven philosophy, and a diversified molecular POCT product portfolio, Cowin Gene is committed to advancing accessible and efficient molecular diagnostics.
From sexually transmitted infection testing to the detection of viruses, bacteria, and fungi, Cowin Gene aims to provide practical molecular diagnostic solutions for healthcare institutions, clinical laboratories, and international medical product distributors.
Related PRODUCTS
Meet COWIN GENE at WHX Bangkok 2026!
NewsJun.09,2026Supporting Ebolavirus Surveillance with Real-time PCR Detection
NewsMay.27,20267 Days To Go Until Whx Lagos 2026!
NewsMay.26,2026Cowingene STI Multiplex Pro Detection Kit-STI21 (Liquid): Advanced Multiplex PCR Diagnostic Solution
NewsNov.19,2026Cowingene Respiratory Pathogen Panel Pro Detection Kit (Liquid): Advanced Molecular Diagnostics for Respiratory Infections
NewsNov.19,2026Cowingene HPV Genotyping Detection Kit - HPV-40 Panel (Liquid): Comprehensive Molecular Testing with PCR Technology
NewsNov.19,2026